| AD | Alzheimer’s disease |
| ALS | Amyotrophic lateral sclerosis |
| APP | Amyloid precursor protein |
| CJD | Creutzfeldt Jacob Disease |
| CK | Cytokeratin |
| Cl-Am | Chlor-amidine |
| CNS | Central nervous system |
| EV | Extracellular vesicle |
| FTD | Frontotemporal dementia |
| GFAP | Glial fibrillary acidic protein |
| HDAC2 | Histone deacetylase 2 |
| HIE | Hypoxic ischaemic encephalopathy |
| iPSC | Induced pluripotent stem cell |
| LPS | Lipopolysaccharide |
| LRRK2 | Leucine-rich repeat kinase 2 |
| MAC | Membrane attack complex |
| MS | Multiple sclerosis |
| MV | Microvesicle |
| NET | Neutrophil extracellular trap |
| PAD | Peptidylarginine deiminase |
| PC3 | Prostate cancer cell line |
| PD | Parkinson disease |
| PNT2 | Control benign prostate cell line |
| PSEN1 | Presenilin 1 |
| RA | Rheumatoid arthritis |
| ROCK | Rho/Rho-associated kinase |
| SNARE | SNAP (Soluble NSF Attachment Protein) REceptor |
| SOD1 | Superoxide dismutase 1 |
| TDP-43 | TAR DNA-binding protein 43 |
| TNFα | Tumour necrosis factor α |
| VCP | Valosin containing protein |